No abstract available
Keywords:
Enhertu; HER2; Herceptin; Herzuma; Kadcyla; Perjeta; Tukysa; Xeloda; ado-trastuzumab; adverse effects; breast cancer; capecitabine; dosage; drug interactions; efficacy; fam-trastuzumab deruxtecan; lactation; paclitaxel; pertuzumab; pregnancy; safety; trastuzumab; tucatinib.
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / genetics*
-
Camptothecin / analogs & derivatives*
-
Camptothecin / therapeutic use
-
Female
-
Humans
-
Immunoconjugates / therapeutic use*
-
Receptor, ErbB-2 / genetics*
-
Trastuzumab / therapeutic use*
Substances
-
Antineoplastic Agents
-
Immunoconjugates
-
trastuzumab deruxtecan
-
ERBB2 protein, human
-
Receptor, ErbB-2
-
Trastuzumab
-
Camptothecin